Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
BROOKS LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 1.623.86-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 1.62 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹165.9 Cr -10.6% -27.5% -49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-10.6%

-27.5%

-49.4%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses